CD4+ T cells from healthy controls showed a marked reduction in PTEN expression 24 h after activation, whereas T cells from MS patients exhibited a significant decrease as early as 2 h post-activation (Figure 2B,C). This evidence concerns the gene CD4 and myeloid sarcoma.